SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Immunome Desmoid Tumor Drug Application Validated in Europe

Immunome said the European Medicines Agency validated its drug application for desmoid tumors.

IMNM

Related stories